Format
Sort by
Items per page

Send to

Choose Destination

Best matches for PEGFILGRASTIM/TU:

Search results

Items: 1 to 20 of 666

1.

[Efficacy of Primary Prophylaxis with Pegfilgrastim after Docetaxel for Castration-Resistant Prostate Cancer].

Koutake Y, Tsurusaki Y, Fujita T, Inoue D, Hanada K, Nakagawa Y.

Gan To Kagaku Ryoho. 2019 Nov;46(11):1721-1725. Japanese.

PMID:
31748481
2.

Hematologic Growth Factors.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
2016 Aug 16.

4.

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel.

Nishimura M, Onoe T, Sakai H, Arase M, Watanabe S, Soyama M, Hashimoto K, Miki M, Tane K, Hirokaga K, Takao S, Matsumoto K.

Anticancer Res. 2019 Aug;39(8):4379-4383. doi: 10.21873/anticanres.13607.

PMID:
31366533
5.

[A Case of Breast Cancer That Was Able to Accomplish Six Courses of TAC for Preoperative Chemotherapy Using Pegfilgrastim].

Kurumiya Y, Sakamoto E.

Gan To Kagaku Ryoho. 2019 Jul;46(7):1179-1181. Japanese.

PMID:
31296826
6.
7.

Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim.

Lee M, Yee J, Kim JY, Kim JY, An SH, Lee KE, Gwak HS.

Asia Pac J Clin Oncol. 2019 Aug;15(4):231-237. doi: 10.1111/ajco.13152. Epub 2019 Apr 17.

PMID:
30997742
8.

[Comparison of Pegfilgrastim and Filgrastim for the Primary Prophylactic Effect for Preventing Febrile Neutropenia in Patients Undergoing Rituximab with Dose-adjusted EPOCH Chemotherapy].

Kataoka T, Sakurashita H, Taogoshi T, Nishigakiuchi R, Murase T, Izumitani S, Saeki Y, Matsuo H.

Yakugaku Zasshi. 2019;139(4):629-633. doi: 10.1248/yakushi.18-00101. Japanese.

9.

[Identification of the Risk Factors for Cabazitaxel-Induced Neutropenia with Preventive Administration of Pegfilgrastim].

Kageyama A, Nakazawa Y, Ando N, Harada D, Kitamura M, Kawakubo T, Asano K.

Gan To Kagaku Ryoho. 2019 Feb;46(2):279-281. Japanese.

PMID:
30914534
10.

LA-EP2006: A Pegfilgrastim Biosimilar.

Hoy SM.

BioDrugs. 2019 Apr;33(2):229-232. doi: 10.1007/s40259-019-00348-3. Review.

PMID:
30887256
11.

Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies.

Harbeck N, Wang J, Otto GP, Gattu S, Krendyukov A.

Future Oncol. 2019 Apr;15(12):1313-1322. doi: 10.2217/fon-2018-0878. Epub 2019 Mar 5.

12.

Randomized phase 3 efficacy and safety trial of proposed pegfilgrastim biosimilar MYL-1401H in the prophylactic treatment of chemotherapy-induced neutropenia.

Waller CF, Ranganna GM, Pennella EJ, Blakeley C, Bronchud MH, Mattano LA Jr, Berzoy O, Voitko N, Shparyk Y, Lytvyn I, Rusyn A, Popov V, Láng I, Beckmann K, Sharma R, Baczkowski M, Kothekar M, Barve A.

Ann Hematol. 2019 May;98(5):1217-1224. doi: 10.1007/s00277-019-03639-5. Epub 2019 Mar 1.

13.

Oral loratadine in the management of G-CSF-induced bone pain: a pilot study.

Duggan C, Murphy L, Costello V, Leary EO, Yousif AD, Blazkova S, Dowling M.

Br J Nurs. 2019 Feb 28;28(4):S4-S11. doi: 10.12968/bjon.2019.28.4.S4.

PMID:
30811242
14.

Oncology nurse phone calls halve the risk of reduced dose intensity of immunochemotherapy: results of the randomized FORTIS study in chronic lymphocytic leukemia.

Ysebaert L, Larcher M, Compaci G, Oberic L, Sahnes L, Banos A, Araujo C, Sommet A, Laurent G, Despas F.

Ann Hematol. 2019 Apr;98(4):931-939. doi: 10.1007/s00277-019-03631-z. Epub 2019 Feb 18.

PMID:
30778715
15.

[Successful Treatment of Advanced Esophageal Cancer with DCF Chemotherapy and Pegfilgrastim].

Gunjigake K, Okamoto K, Gabata R, Yamaguchi T, Ninomiya I, Fushida S, Ohta T.

Gan To Kagaku Ryoho. 2019 Jan;46(1):61-63. Japanese.

PMID:
30765644
16.
17.

Pegfilgrastim-jmdb/MYL-1401H: A Pegfilgrastim Biosimilar.

Hoy SM.

BioDrugs. 2019 Feb;33(1):117-120. doi: 10.1007/s40259-019-00334-9. Review.

PMID:
30701419
18.

Efficacy of pegfilgrastim to support neoadjuvant dose-dense epirubicin and cyclophosphamide chemotherapy in breast cancer.

Wang X, He Y, Wang T, Xie Y, Li J, Ouyang T, Fan Z.

Support Care Cancer. 2019 Aug;27(8):3019-3025. doi: 10.1007/s00520-018-4572-8. Epub 2019 Jan 4.

PMID:
30607682
19.

[A Case of Arteritis That Developed after Pegfilgrastim Administration during Chemotherapy for Breast Cancer].

Chino T, Oba T, Yamamoto K, Takekoshi D, Iesato A, Ito T, Kanai T, Maeno K, Ito K.

Gan To Kagaku Ryoho. 2018 Dec;45(12):1771-1774. Japanese.

PMID:
30587739
20.

[Safety Profile of the Combination of Prophylactic Pegfilgrastim and Cabazitaxel for Japanese Patients with Castration Resistant Prostate Cancer].

Azuma K, Kawakami K, Yuasa T, Sugisaki T, Hashimoto K, Aoyama T, Suzuki K, Yonese J, Hama T.

Gan To Kagaku Ryoho. 2018 Dec;45(12):1737-1742. Japanese.

PMID:
30587731

Supplemental Content

Loading ...
Support Center